Search Salary Now

Trending now: Meta, Amazon, Apple, Netflix, Google, Airbnb, Uber, Linkedin, Salesforce

Ascentage Pharma Group Inc H1B Salary 2023

10 records was found, Median Salary is $76003. 0 percents of the salary are above $200K, 0 percents of the salary are between $150K and $200K, 20 percents of the salary are between $100K and $150K, 80 percents of the salary are less than $100k



<100k80% Complete (success)
100k-150k20% Complete (success)
150k-200k0% Complete (warning)
>200k0% Complete (danger)
EMPLOYERJOB TITLEBASE SALARYLOCATIONSUBMIT DATESTART DATE
ASCENTAGE PHARMA GROUP INCACCOUNTING ANALYST ? US & CHINA76,003ROCKVILLE, MD05/21/202010/01/2020
ASCENTAGE PHARMA GROUP INCACCOUNTING ANALYST ñ US & CHINA76,003ROCKVILLE, MD03/20/202009/01/2020
ASCENTAGE PHARMA GROUP INCACCOUNTING AND FINANCE ASSOCIATE82,390ROCKVILLE, MD04/25/202310/01/2023
ASCENTAGE PHARMA GROUP INCINSTRUCTIONAL DESIGNER62,088ROCKVILLE, MD09/08/202010/01/2020
ASCENTAGE PHARMA GROUP INCINSTRUCTIONAL DESIGNER67,000ROCKVILLE, MD05/10/202310/01/2023
ASCENTAGE PHARMA GROUP INCNETWORK AND COMPUTER SYSTEMS ADMINISTRATOR68,385ROCKVILLE, MD06/17/202210/01/2022
ASCENTAGE PHARMA GROUP INCREGULATORY AFFAIRS OPERATIONS MANAGER110,000ROCKVILLE, MD03/18/202203/28/2022
ASCENTAGE PHARMA GROUP INCSR. REGULATORY OPERATIONS MANAGER140,000ROCKVILLE, MD10/21/202211/13/2022
ASCENTAGE PHARMA GROUP INCSTATISTICAL DATA MANAGEMENT ASSOCIATE79,000ROCKVILLE, MD03/25/201909/01/2019
ASCENTAGE PHARMA GROUP INCTRAINING AND DEVELOPMENT SPECIALIST, HUMAN RESOURCES59,072ROCKVILLE, MD03/20/201909/01/2019

This website indexes the Labor Condition Application (LCA) disclosure data from the United States Department of Labor (DOL).
Prior to filing an H-1B petition with the USCIS, an employer must file an LCA with the DOL.
An LCA is used by employers as supporting evidence for the petition for an H-1B visa.
DOL disclosure data does not indicate the employer's intended use for the LCA.

Indexed more than 4.8 million records between Oct 2013 and Sep 2023
Copyright @ h1bdata.info. All rights reserved.
Contact us     Privacy policy     Advertise